-
[YEAR:15-4-2005]Levell,J., Astles,P., Eastwood,P., Cairns,J., Houille,O., Aldous,S., Merriman,G., Whiteley,B., Pribish,J., Czekaj,M., Liang,G., Maignan,S., Guilloteau,J.P., Dupuy,A., Davidson,J., Harrison,T., Morley,A., Watson,S., Fenton,G., McCarthy,C., Romano,J., Mathew,R., Engers,D., Gardyan,M., Sides,K., Kwong,J., Tsay,J., Rebello,S., Shen,L., Wang,J., Luo,Y., Giardino,O., Lim,H.K., Smith,K. and Pauls,H.
Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptase
Bioorg Med Chem13, 2859-2872. PubMed Europe PubMed DOI I
2005
